SurgOnc Today®

Outside the OR: The Global Cancer Burden, the SSO, and You!

In this episode of Outside the OR, Dr. Russell Berman sits down with Dr. Peter Kingham to talk about the rising global cancer burden and why it matters to every surgical oncologist — and every patient. Drawing from his extensive work in West Africa and his leadership in global surgery, Dr. Kingham shares what cancer care really looks like in low-resource settings and how individual surgeons can make a meaningful impact. From groundbreaking research to on-the-ground challenges, this conversation shines a light on global cancer disparities. Tune in for an eye-opening, inspiring discussion about the future of cancer care worldwide.

SSO Education Series: Management of Male Breast Cancer

In this episode of SurgOnc Today, SSO Breast Disease Site Working Group members Drs. David Anderson, Fred Dirbas, and Suzanne Klimberg dive into management of male breast cancer. The speakers discuss unique considerations for this population as well as the similarities and overlap when treating female breast cancer.

ASO Article Series: "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?"

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Mecker G. Möller crucial questions regarding colorectal peritoneal metastasis (CRC-PM) management, particularly concerning the optimal applications of HIPEC in clinical practice, as reported in the article, "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?"

SSO Education Series: Native American Heritage Month

In this episode of SurgOnc Today, Jonathan Baines, MD, Donald Warne, MD, and Lori Arviso Alvord, MD discuss advocacy and mentoring of Native American and URM Trainees.

SSO Education Series: Duodenal Adenocarcinoma: Tailoring Surgical Approach by Tumor Location

In this episode of SurgOnc Today, Mark Knab, Charles Vining, and Kelvin Allenson discuss how the anatomic location of duodenal adenocarcinoma—from the first to the fourth portion—fundamentally shapes surgical decision-making. Discussion highlights include criteria for pancreaticoduodenectomy versus segmental or limited resections, the role of margin status and lymphadenectomy, and evolving data guiding resection strategy for non-ampullary duodenal cancers. Designed for practicing surgical oncologists, this episode emphasizes operative judgment, outcomes data, and the balance between oncologic adequacy and surgical morbidity.